RESPIRATORY PANEL BY PCR (40)

The RESPIRATORY PANEL BY PCR (40) is a multiplex molecular test that simultaneously detects genetic material from 40 common viral and bacterial respiratory pathogens from a single nasopharyngeal or oropharyngeal swab. Using real-time PCR technology, the panel offers high sensitivity and specificity to identify the causative agent of acute respiratory illness, enabling fast and reliable pathogen identification for targeted clinical management.

This test is particularly valuable for distinguishing between viral and bacterial infections, guiding antiviral or antibiotic decisions, and informing infection-control measures in community and healthcare settings across Dubai and the UAE. It is suitable for symptomatic patients (adults and children), high‑risk individuals (elderly, immunocompromised, pregnant), healthcare workers, and when rapid etiologic diagnosis is needed during seasonal outbreaks.

Samples can be collected discreetly at home by certified phlebotomists or collection teams arranged through the service, with laboratory reporting typically available within 24–48 hours depending on courier and lab workload. Note that PCR detects pathogen nucleic acid and may remain positive after clinical recovery; results should be interpreted alongside clinical assessment by your treating physician.

• SARS‑CoV‑2 (COVID‑19)
• Influenza A and Influenza B
• Respiratory Syncytial Virus (RSV) A/B
• Human Rhinovirus/Enterovirus
• Adenovirus
• Atypical bacteria panel (Mycoplasma pneumoniae, Chlamydophila pneumoniae, Bordetella spp.)

• Sudden onset of fever, cough, sore throat, or shortness of breath
• Severe or worsening respiratory symptoms, or symptoms in high‑risk patients
• After known exposure to confirmed respiratory infection during outbreaks
• For differential diagnosis when multiple respiratory pathogens are possible
• Prior to admission to hospital or congregate settings where pathogen identification affects isolation

• Comprehensive detection of 40 respiratory pathogens from one sample
• High sensitivity and specificity using PCR technology
• Discreet home sample collection across Dubai with certified collectors
• Fast laboratory turnaround (typically 24–48 hours) to support timely care
• Actionable results to guide targeted treatment and infection control

• Sample type: nasopharyngeal and/or oropharyngeal swab collected by trained personnel
• No fasting required; continue routine medications unless instructed otherwise
• Inform the collector of recent antiviral or antibiotic use and recent vaccinations
• Be available for home pickup within scheduled appointment window in Dubai (ensure valid UAE ID/Emirates ID)